The impact of GLP 1 analogues on fertility restoration in patients with Polyendocrine Metabolic Ovarian Syndrome (PMOS) - Narrative Review
DOI:
https://doi.org/10.12775/QS.2026.68.74321Keywords
Polycystic ovary syndrome (PCOS), PMOS, infertility in polycystic ovary syndrome, GLP-1 agonist, 'fertility', female reproductive endocrinology, female infertility, polyendocrine metabolic ovarian syndromeAbstract
Background. The Polyendocrine Metabolic Ovarian Syndrome (PMOS), previously named as Polycystic Ovary Syndrome (PCOS) is common endocrine and metabolic disorder. It is the main cause of female infertility. The manifestation is heterogeneous and contain coexisting hyperandrogenism, obesity, insulin resistance. The PMOS‑associated infertility treatment is multidisciplinary process involving pharmacotherapy, diet and lifestyle changes. Synthetic analogues of endogenous GLP-1 (GLP-1 Ras) are register for treatment of type 2 diabetes and obesity.
Aim. This study aimed to assess the effectiveness of GLP‑1 RAs in improving reproductive outcomes in women with PMOS.
Material and methods. Narrative literature review was conducted through a search of electronic databases: PubMed and Google Scholar. The search covered clinical trials, observational studies and articles from 2020–2026 and used combinations of the following keywords: “polycystic ovary syndrome”, “GLP 1 analogues”, ”infertility” and related terms. Additional articles were identified by screening reference lists of key publications.
Results. Clinical study revealed that GLP-1 Ras decrease body weight as well as improve metabolic) and hormonal parameters in patients with PMOS. GLP-1 Ras contribute to restoring the function of the hypothalamus–pituitary–ovarian axis. In addition, their improve menstrual regularity, in women with PMOS as well as pregnancy and ovulation rates. GLP‑1 RAs may enhance spontaneous and IVF pregnancy and ovulation rates and exert suppression of pro-inflammatory agents and recovering maternal-fetal immune tolerance.
Conclusions. Collectively, the broad metabolic, hormonal and immunometabolic effects of GLP‑1 RAs make them a valuable therapeutic strategy for improving fertility outcomes in obese women with PMOS, although the further studies are required—particularly those assessing their safety during the preconception period.
References
Austregésilo de Athayde De Hollanda Morais, B., Martins Prizão, V., de Moura de Souza, M., Ximenes Mendes, B., Rodrigues Defante, M. L., Cosendey Martins, O., & Rodrigues, A. M. (2024). The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials. Journal of Diabetes and Its Complications, 38(10). https://doi.org/10.1016/j.jdiacomp.2024.108834
Bader, S., Bhatti, R., Mussa, B., & Abusanana, S. (2024). A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS. Women’s Health (London, England), 20. https://doi.org/10.1177/17455057241234530
Baranowska-Bik, A. (2022). Therapy of obesity in women with PCOS using GLP-1 analogues — benefits and limitations [Terapia otyłości u kobiet z PCOS przy zastosowaniu analogów GLP-1 — korzyści i ograniczenia]. Endokrynologia Polska, 73(3), 627–643. https://doi.org/10.5603/EP.A2022.0047
Cena, H., Chiovato, L., & Nappi, R. E. (2020). Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. The Journal of Clinical Endocrinology and Metabolism, 105(8), e2695. https://doi.org/10.1210/CLINEM/DGAA285
Dao, K., Shechtman, S., Weber-Schoendorfer, C., Diav-Citrin, O., Murad, R. H., Berlin, M., Hazan, A., Richardson, J. L., Eleftheriou, G., Rousson, V., Diezi, L., Haefliger, D., Simões-Wüst, A. P., Addor, M. C., Baud, D., Lamine, F., Panchaud, A., Buclin, T., Girardin, F. R., & Winterfeld, U. (2024). Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services. BMJ Open, 14(4), e083550. https://doi.org/10.1136/BMJOPEN-2023-083550
Duah, J., & Seifer, D. B. (2025). Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review. Reproductive Biology and Endocrinology : RB&E, 23(1). https://doi.org/10.1186/S12958-024-01339-Y
Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews. Endocrinology, 14(5), 270–284. https://doi.org/10.1038/NRENDO.2018.24
Forslund, M., Wändell, P., Forsberg, L., Österberg, M., Dagerhamn, J., Wernersson, E., Kärrman Fredriksson, M., Ringborg, A., & Lindén Hirschberg, A. (2026). GLP-1 receptor agonist treatment in women with polycystic ovary syndrome—a systematic review and meta-analysis. European Journal of Endocrinology, 194(3), S25–S39. https://doi.org/10.1093/EJENDO/LVAG033
Gorry, A., White, D. M., & Franks, S. (2006). Infertility in polycystic ovary syndrome. Endocrine 2006 30:1, 30(1), 27–33. https://doi.org/10.1385/ENDO:30:1:27
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022). Polycystic ovary syndrome. The Lancet Diabetes & Endocrinology, 10(9), 668–680. https://doi.org/10.1016/S2213-8587(22)00163-2
Liu, X., Zhang, Y., Zheng, S. Y., Lin, R., Xie, Y. J., Chen, H., Zheng, Y. X., Liu, E., Chen, L., Yan, J. H., Xu, W., Mai, T. T., & Gong, Y. (2017). Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight/obese polycystic ovary syndrome. Clinical Endocrinology, 87(6), 767–774. https://doi.org/10.1111/CEN.13454
Parua, S., Purkait, M. P., Bhattacharjee, A., Thangarajan, R., Rammohan, S., Islam, K., Bhattacharya, K., & Syamal, A. K. (2025). Exploring female infertility: A comprehensive review of polycystic ovary syndrome (PCOS) and its impact on reproductive health. Obesity Medicine, 55, 100619. https://doi.org/10.1016/J.OBMED.2025.100619
Romero, T. B., de Sousa Sobral, D., Aguiar, L. A. A., Ponte, H. A. A., Romero Filho, R. E., Montenegro, A. L. R., Maia, M. G. R., Marques, T. G., de Oliveira Martins, L., & Cavalcante, M. B. (2026). Interconnection between polycystic ovary syndrome, immune disorders, and reproductive outcomes. Reproduction & Fertility, 7(2), RAF250186. https://doi.org/10.1530/RAF-25-0186
Ruiz-González, D., Cavero-Redondo, I., Hernández-Martínez, A., Baena-Raya, A., Martínez-Forte, S., Altmae, S., Fernández-Alonso, A. M., & Soriano-Maldonado, A. (2024). Comparative efficacy of exercise, diet and/or pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity: a systematic review and network meta-analysis. Human Reproduction Update, 30(4), 472–487. https://doi.org/10.1093/HUMUPD/DMAE008
Salamun, V., Jensterle, M., Janez, A., & Bokal, E. V. (2018). Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. European Journal of Endocrinology, 179(1), 1–11. https://doi.org/10.1530/EJE-18-0175
Samarasinghe, S. N. S., Woods, C., & Miras, A. D. (2024). Bariatric Surgery in Women with Polycystic Ovary Syndrome. Metabolism, 151, 155745. https://doi.org/10.1016/J.METABOL.2023.155745
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020). Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Molecular Metabolism, 35, 100937. https://doi.org/10.1016/J.MOLMET.2020.01.001
Scragg, J., Hobson, A., Willis, L., Taylor, K. S., Dixon, S., & Jebb, S. A. (2024). Effect of Weight Loss Interventions on the Symptomatic Burden and Biomarkers of Polycystic Ovary Syndrome : A Systematic Review of Randomized Controlled Trials. Annals of Internal Medicine, 177(12), 1664–1674. https://doi.org/10.7326/M23-3179
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023). Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. Journal of Clinical Medicine 2023, Vol. 12, Page 1454, 12(4), 1454. https://doi.org/10.3390/JCM12041454
Sola-Leyva, A., Pathare, A. D. S., Apostolov, A., Aleksejeva, E., Kask, K., Tammiste, T., Ruiz-Durán, S., Risal, S., Acharya, G., & Salumets, A. (2024). The hidden impact of GLP‐1 receptor agonists on endometrial receptivity and implantation. Acta Obstetricia et Gynecologica Scandinavica, 104(2), 258. https://doi.org/10.1111/AOGS.15010
Sridharan, K., & Sivaramakrishnan, G. (2025). Expanding therapeutic horizons: glucagon-like peptide-1 receptor agonists and sodium glucose transporter-2 inhibitors in poly cystic ovarian syndrome: a comprehensive review including systematic review and network meta-analysis of randomized clinical tri…. Diabetology & Metabolic Syndrome, 17(1), 168. https://doi.org/10.1186/S13098-025-01730-8
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024). Polycystic ovary syndrome. Nature Reviews. Disease Primers, 10(1). https://doi.org/10.1038/S41572-024-00511-3
Su, P., Chen, C., & Sun, Y. (2025). Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation. Journal of Ovarian Research 2025 18:1, 18(1), 34-. https://doi.org/10.1186/S13048-025-01621-6
Tavares, A. C. M., Martins, M. Y. M., de Souza, G. F., Lima, E. M., Rocha, C. A., de Souza, L. C., Simões, J. M. L., de Araújo, N. O., & Cavalcante, M. B. (2025). Immunological effects of GLP-1 analogs on female reproduction: Therapeutic perspectives for infertility and recurrent pregnancy loss. In Journal of Reproductive Immunology (Vol. 169). Elsevier Ireland Ltd. https://doi.org/10.1016/j.jri.2025.104538
Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S. E., Joham, A. E., Costello, M. F., Patil, M., Rees, D. A., Berry, L., Cree, M. G., Zhao, H., Norman, R. J., Dokras, A., Piltonen, T., & Global Name Change Consortium. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet (London, England), 0(0). https://doi.org/10.1016/S0140-6736(26)00717-8
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., Andersen, M., Azziz, R., Balen, A., Baye, E., Boyle, J., Brennan, L., Broekmans, F., Dabadghao, P., Devoto, L., Dewailly, D., Downes, L., … Yildiz, B. O. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, 33(9), 1602–1618. https://doi.org/10.1093/HUMREP/DEY256
Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., Norman, R. J., Mousa, A., Joham, A. E., Arlt, W., Azziz, R., Balen, A., Bedson, L., Berry, L., Boivin, J., … Tan, K. (2023). Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism, 108(10), 2447. https://doi.org/10.1210/CLINEM/DGAD463
Voros, C., Chatzinikolaou, F., Papapanagiotou, I., Polykalas, S., Mavrogianni, D., Koulakmanidis, A.-M., Athanasiou, D., Kanaka, V., Bananis, K., Athanasiou, A., Athanasiou, A., Papadimas, G., Tsimpoukelis, C., Vaitsis, D., Karpouzos, A., Daskalaki, M. A., Kanakas, N., Theodora, M., Thomakos, N., … Daskalakis, G. (2026). A Systematic Review on GLP-1 Receptor Agonists in Reproductive Health: Integrating IVF Data, Ovarian Physiology and Molecular Mechanisms. International Journal of Molecular Sciences, 27(2), 759. https://doi.org/10.3390/IJMS27020759
Wang, T., Zhang, T., Wang, J., & Lu, T. (2026). Evolving PCOS Management: From Symptom Control to Phenotype-Targeted Therapy. Diabetes, Metabolic Syndrome and Obesity, 19, 1–11. https://doi.org/10.2147/DMSO.S560296
World Health Organization. (2023). Infertility prevalence estimates 1990–2021. Geneva:
Licence: CC BY-NC-SA 3.0 IGO
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Martyna Więcławek, Magdalena Grzymek, Makary Hejduk, Joanna Kadłuczka, Weronika Kępa , Katarzyna Kraska , Aneta Sobek, Justyna Bury, Katarzyna Pawłucka , Aleksandra Pawłucka , Jan Potoniec
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 159
Number of citations: 0
